RBRK stock forecast, quote, news & analysis
Rubrik Inc is a company that offers data security solutions to organizations ranging from companies world-wide to mid-sized and smaller customers... Show more
Rubrik, Inc. (RBRK) Stock Analysis: MEDITECH Partnership Boosts Healthcare Focus
Key Takeaways
- Rubrik, Inc. reported strong fiscal 2026 results earlier in the year, with subscription annual recurring revenue (ARR) growing 34% year-over-year.
- A May 2026 strategic partnership with MEDITECH for cyber resilience in healthcare drove notable stock gains in recent trading sessions.
- Multiple analyst firms, including Oppenheimer and BTIG, have issued positive ratings and price targets on the stock.
- Investors are awaiting first-quarter fiscal 2027 earnings scheduled for June 4, 2026, which could influence near-term volatility.
- The company continues to emphasize AI-driven data security and cloud solutions amid expanding cybersecurity demand.
Current Market Snapshot
In recent weeks, Rubrik, Inc. shares have shown resilience amid broader technology sector movements, supported by targeted growth initiatives in data security. The stock has benefited from positive sentiment around healthcare sector expansion and analyst endorsements, though it remains sensitive to earnings expectations and macroeconomic factors affecting high-growth software companies. Trading activity reflects investor interest in the company’s subscription-based model and cyber resilience offerings, with price behavior tied closely to partnership announcements and sector trends.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of AI trading bots designed to navigate dynamic market conditions across thousands of tickers. While Tickeron offers hundreds of AI trading bots with varying strategies, timeframes, performance metrics, and ticker coverage, only the top performers suited to prevailing environments are featured in this section. Available bots demonstrate diverse statistics, including win rates, profit factors, and drawdown levels, allowing users to explore options aligned with different risk profiles and trading styles. For investors seeking automated approaches to stocks like RBRK, this resource provides valuable insights into algorithmic opportunities. Explore the full selection at Trending AI Robots.
Recent Developments Driving RBRK Price Action
Over the past 30 days, Rubrik’s stock has responded primarily to a key commercial partnership and supportive analyst commentary. On May 19, 2026, the company announced a collaboration with MEDITECH to deliver unified cloud and on-premises cyber resilience solutions for MEDITECH Expanse healthcare customers. The integration provides immutable data protection, native threat detection, rapid recovery capabilities, and cloud-based archival through Rubrik Security Cloud. This development directly enhanced Rubrik’s positioning in the healthcare vertical, where data security and regulatory compliance are critical. The announcement contributed to an approximate 8.5% stock increase in subsequent sessions, with the share price rising notably on May 29 amid broader market gains.
Analyst actions reinforced positive momentum. Oppenheimer upgraded the stock to Outperform with an $85 price target, citing the partnership’s potential to expand Rubrik’s addressable market in healthcare cybersecurity. BTIG reiterated its Buy rating following positive customer checks, while earlier initiations from firms such as Wolfe Research (Outperform) and Jefferies (Buy) continued to support sentiment. These ratings highlighted Rubrik’s growth trajectory in subscription annual recurring revenue and its focus on AI-enhanced security features.
Additional context includes the company’s April 30, 2026, launch of the Rubrik Practitioner Community, aimed at cybersecurity professionals, which bolstered brand visibility. No major regulatory or macroeconomic events specifically targeted Rubrik in the period, though sector-wide demand for cyber resilience amid rising AI-related threats provided a supportive backdrop. Price action remained linked to these catalysts, with limited volatility outside of the partnership-driven move and ongoing positioning ahead of the June 4 earnings release.
2026 Outlook and Key Factors to Monitor
As Rubrik enters the remainder of 2026, investors will focus on the company’s ability to sustain subscription ARR growth through expanded healthcare and enterprise adoption of its cyber resilience platform. Key themes include continued integration of artificial intelligence for threat detection and data management, alongside potential expansion of cloud and on-premises offerings. Strategic partnerships, such as the recent MEDITECH collaboration, could serve as models for additional vertical penetration.
Competitive dynamics in the cybersecurity and data management space, including offerings from larger technology providers, represent an ongoing consideration. Monitoring quarterly execution on revenue growth, gross margins, and free cash flow will be essential, as will any updates on product roadmaps or new customer wins. Regulatory developments around data privacy and cybersecurity standards may also influence operational priorities. Broader economic conditions affecting IT spending and cloud adoption will shape the environment, with emphasis remaining on balancing innovation investments against profitability targets.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Momentum Indicator for RBRK turns negative, indicating new downward trend
RBRK saw its Momentum Indicator move below the 0 level on June 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator turned negative. In of the 34 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for RBRK moved out of overbought territory on June 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator moved out of overbought territory. In of the 8 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for RBRK turned negative on June 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 18 similar instances when the indicator turned negative. In of the 18 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RBRK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
RBRK broke above its upper Bollinger Band on May 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where RBRK advanced for three days, in of 130 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 99 cases where RBRK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.272). P/E Ratio (28.386) is within average values for comparable stocks, (69.167). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). RBRK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.022). P/S Ratio (9.551) is also within normal values, averaging (144.771).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RBRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RBRK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ComputerCommunications